Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection of Patients for Maintenance Therapy-Reference-Cited by-同舟云学术

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection of Patients for Maintenance Therapy

Published:2010-04 Issue:4 Volume:5 Page:540-545
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sun Jong-Mu,Park Joon Oh,Won Young-Woong,Kim Jung-Hoon,Yun Jina,Lee Jeeyun,Park Yeon Hee,Ahn Jin Seok,Ahn Myung-Ju,Park Keunchil

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference19 articles.

1. Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results;Breathnach;J Clin Oncol,2001

2. The role of maintenance chemotherapy in advanced nonsmall cell lung cancer;Jalal;Curr Opin Oncol,2009

3. Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigm;Mok;Cancer,2009

4. Duration of chemotherapy for metastatic non-small-cell lung cancer: more may be better after all;Schiller;J Clin Oncol,2009

5. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure?;Socinski;J Clin Oncol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab alone or with chemotherapy for metastatic non-small-cell lung cancer: A systematic review and network meta-analysis;Critical Reviews in Oncology/Hematology;2022-05

2. Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma;Investigational New Drugs;2019-02-21

3. A phase II study of carboplatin, pemetrexed, and bevacizumab followed by erlotinib and bevacizumab maintenance for non-squamous non-small cell lung cancer with wild-type EGFR (HOT1101);International Journal of Clinical Oncology;2018-07-19

4. Systemic therapy treatment patterns in patients with advanced non-small cell lung cancer (NSCLC): PIvOTAL study;European Journal of Cancer Care;2017-07-27

5. Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting;ANTICANCER RES;2017